Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
"Tapentadol" - A Novel Analgesic
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Tayal G et al. – Tapentadol is a new analgesic drug with a dual mode of action, hence has efficacy in a broad spectrum of acute and chronic pain models and possibly an improved tolerability profile. It combines moderate mu–opioid agonist activity with NE reuptake inhibition in a single, nonracemic molecule. No metabolic activation of tapentadol is necessary for analgesia, and it has no active metabolites. Further RCTs are needed to establish its routine use in postoperative patients.
Related Articles
Tapentadol immediate release for the relief of moderate-to-severe acute pain
Expert Opinion in Pharmacotherapy, 10/08/09
Relevance Score: 92%
Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule
Drugs of Today, 10/19/09
Relevance Score: 90%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09
High-frequency, high-intensity transcutaneous electrical nerve stimulation as treatment of pain after surgical abortion
Pain, 12/04/09
A systematic review of comparative studies indicates that paravertebral block is neither superior nor safer than epidural analgesia for pain after thoracotomy
Scandinavian Journal of Pain, 12/04/09
Article Search
Sponsor


See Latest Articles


